SGK
REGN icon

Steigerwald Gordon & Koch’s Regeneron Pharmaceuticals REGN Stock Holding History

Steigerwald Gordon & Koch’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115K Buy
185
+175
+1,750% +$119K 0.01% 203
2026
Q1 		$7.73K Sell
10
-2
-17% -$1.53K ﹤0.01% 559
2025
Q4 		$9.26K Buy
12
+2
+20% +$1.36K ﹤0.01% 584
2025
Q3 		$5.62K Buy
+10
New +$5.65K ﹤0.01% 608

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Steigerwald Gordon & Koch's REGN Position: Q2 2026 in Review

Steigerwald Gordon & Koch increased its Regeneron Pharmaceuticals (REGN) stake by 1,750% in Q2 2026, buying an estimated $119K and bringing the position to 185 shares worth $115K. The position accounts for 0.01% of the portfolio, ranked #203.

Steigerwald Gordon & Koch first reported a position in REGN in Q3 2025 and has held it in 4 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Steigerwald Gordon & Koch held 185 shares of Regeneron Pharmaceuticals worth $115K as of Q2 2026.
  • Steigerwald Gordon & Koch bought 175 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $119K.
  • Regeneron Pharmaceuticals made up 0.01% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #203 holding.
  • Steigerwald Gordon & Koch first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.